BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2642482)

  • 21. Platelet PGI2 receptor affinity is reduced in pre-eclampsia.
    Klockenbusch W; Hohlfeld T; Wilhelm M; Somville T; Schrör K
    Br J Clin Pharmacol; 1996 Jun; 41(6):616-8. PubMed ID: 8799531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The platelet rebound phenomenon during PGI2-infusion occurs at the receptor level.
    Steurer G; Fitscha P; Sinzinger H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):435-8. PubMed ID: 2465947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the prostacyclin receptor by radiation inactivation.
    Leigh PJ; Cramp WA; MacDermot J
    J Biol Chem; 1984 Oct; 259(20):12431-6. PubMed ID: 6208187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a solubilized prostaglandin E2 receptor from renal medulla with a pertussis toxin-reactive guanine nucleotide regulatory protein.
    Watanabe T; Umegaki K; Smith WL
    J Biol Chem; 1986 Oct; 261(29):13430-7. PubMed ID: 2875997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubilization of pituitary GnRH binding sites by means of a zwitterionic detergent.
    Winiger BP; Birabeau MA; Lang U; Capponi AM; Sizonenko PC; Aubert ML
    Mol Cell Endocrinol; 1983 Jul; 31(1):77-91. PubMed ID: 6309585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in prostacyclin platelet receptors in active spontaneous angina.
    Neri Serneri GG; Modesti PA; Fortini A; Abbate R; Lombardi A; Gensini GF
    Lancet; 1984 Oct; 2(8407):838-41. PubMed ID: 6148573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
    Armstrong RA; Humphrey PP; Lumley P
    Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the prostacyclin receptor by use of [15-3H1]19-(3-azidophenyl)-20-norisocarbacyclin, an irreversible specific photoaffinity probe.
    Ito S; Hashimoto H; Negishi M; Suzuki M; Koyano H; Noyori R; Ichikawa A
    J Biol Chem; 1992 Oct; 267(28):20326-30. PubMed ID: 1400351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics.
    Eggerman TL; Hartzell CJ; Selfe S; Andersen NH
    Thromb Res; 1987 Mar; 45(5):645-59. PubMed ID: 3296302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of platelet [3H] iloprost binding by cholesterol, dibucaine and pentoxifylline.
    Jaschonek K; Funck M; Muller CP; Schmidt H
    Prog Clin Biol Res; 1989; 301():321-5. PubMed ID: 2477853
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
    Jaschonek K; Faul C; Daiss W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
    Miquel MC; Emerit MB; Bolaños FJ; Schechter LE; Gozlan H; Hamon M
    J Neurochem; 1990 Nov; 55(5):1526-36. PubMed ID: 2213008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubilization and characterization of B2 bradykinin receptors from cultured human fibroblasts.
    Faussner A; Heinz-Erian P; Klier C; Roscher AA
    J Biol Chem; 1991 May; 266(15):9442-6. PubMed ID: 1851746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets.
    Dutta-Roy AK; Kahn NN; Sinha AK
    Life Sci; 1991; 49(16):1129-39. PubMed ID: 1654491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detergent solubilization, functional reconstitution, and partial purification of epithelial amiloride-binding protein.
    Sariban-Sohraby S; Benos DJ
    Biochemistry; 1986 Aug; 25(16):4639-46. PubMed ID: 3768303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of a novel circulating anti-prostacyclin receptor antibody.
    Kahn NN; Bauman WA; Sinha AK
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8779-82. PubMed ID: 9238054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of prostacyclin receptors in luteinizing hormone-releasing hormone immortalized neurons: role in the control of hormone secretion.
    Pimpinelli F; Rovati GE; Capra V; Piva F; Martini L; Maggi R
    Endocrinology; 1999 Jan; 140(1):171-7. PubMed ID: 9886823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of surface expression of human platelet prostacyclin receptors by cholesterol, dibucaine and pentoxifylline.
    Funck M; Muller CP; Jaschonek K
    Thromb Res; 1988 Nov; 52(4):343-7. PubMed ID: 2462288
    [No Abstract]   [Full Text] [Related]  

  • 39. 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate-solubilized binding sites for 2-[125I]iodomelatonin in chick brain retain sensitivity to guanine nucleotides.
    Ying SW; Niles LP
    J Neurochem; 1991 Feb; 56(2):580-6. PubMed ID: 1846401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptors for PGI2 and PGD2 on human platelets.
    Siegl AM
    Methods Enzymol; 1982; 86():179-92. PubMed ID: 6290840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.